Last reviewed · How we verify

NCT04835740

Effects of High-intensity Interval Aerobic Training on Balance, Walking Capacity, and Quality of Life in Patients With Sub-acute Stroke

Completed NA Last updated 8 April 2021
What this trial tests

NA trial testing High intensity Interval Training in Stroke, Ischemic in 50 participants. Completed in 16 March 2021.

Timeline
5 October 2020
Primary endpoint
15 November 2020
16 March 2021

Quick facts

Lead sponsorAkhtar Saeed Medical and Dental College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date5 October 2020
Primary completion15 November 2020
Estimated completion16 March 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Akhtar Saeed Medical and Dental College

Who can join

Adults 18 to 75, any sex, with Stroke, Ischemic or Cerebrovascular Accident. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemiplegia is one of the most common sequelae of stroke. Stroke is the leading cause of disability in adults all around the world. Stroke survivors can suffer several neurological impairments and deficits which have an important impact on patient's quality of life and which increase the costs for health and social services. After stroke, impairments in ADLs and functional status, deterioration in health related quality of life can be seen. The purpose of this study is to Determine the effect of Aerobic exercise training on Balance, Walking capacity and quality of life in sub-acute stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity Interval Training

Trials testing the same drug.

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04835740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing